SOPHiA GENETICS
Company Snapshot
Founded: 2011
Entity Type: Public
Employees: 423
Region: Europe, the Middle East, and Africa (EMEA)
Revenue: $65.2 Millions
Revenue Year: 2024
Headquarter: Rolle, Switzerland
Key Geographics: U.S., Switzerland, France, Italy, Spain, Rest of Europe, Europe, Middle East, Africa, Asia-Pacific, Latin America
Company Overview
SOPHiA GENETICS is the creator of a global data-sharing network. The company works with customers from over 750 institutions in over 72 countries. Its network advances data-driven medicine to improve health outcomes and economics worldwide.
SOPHiA GENETICS offers a cloud-based Software-as-a-Service platform—the SOPHiA DDM platform—that enables healthcare institutions to get quick, robust insights from their data. They apply the company’s technology to diseases such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support discoveries, treatment, and drug development efforts.
Financial Highlights (FY 2023)
Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***
This information is available for BCC Research members only.
SOPHiA GENETICS In News
Company's Business Segments
- SOPHiA DDM Platform : This segment offers a broad range of genomics applications across oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism, and other disease areas.
- Workflow equipment and services : This segment provides all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services rendered primarily to clinical customers.
Applications/End User Industries
- Biotechnology
- Healthcare
BCC Research Beacon 